Original language | English (US) |
---|---|
Pages (from-to) | 1015-1033 |
Number of pages | 19 |
Journal | J.JAP.BIOCHEM.SOC. |
Volume | 45 |
Issue number | 12 |
State | Published - 1973 |
Externally published | Yes |
Bibliographical note
Funding Information:We would like to thank the patients and families for their kind cooperation and their participation in this study. We thank the Bertarelli platform for Gene Therapy at EPFL (Lausanne, Switzerland) for viral vector production of AAV-CMV-GFP. We thank Claire El Yazidi and Morgane Thomas, from the Cell Reprogramming and Differentiation Facility at U 1251/Marseille Medical Genetics (Marseille, France) for reprogrammation and characterization of patient's II.2 fibroblasts into iPSC cell line and for providing control iPSC lines. We thank Dr Antoine Salloum for performing skin biopsies.
Funding Information:
French Association against Myopathies ‘Association Française contre les Myopathies’; the ‘Agence Universitaire de la Fran-cophonie’ (AUF); A.MIDEX Foundation; Fellowship from the HERMES Programme of the European Union’s Seventh Frame-work Programme for research, technological development and demonstration (to L.E.-B.); French Association against Myopathies ‘Association Française contre les Myopathies’ (AFM to L.E.-B.); ‘Association ADN’ (to K.R.).